Pallas vs Ro: Which GLP-1 Telehealth Is Right for You?

If you're evaluating GLP-1 telehealth platforms, Ro (Roman) is probably on your shortlist — they were one of the earliest large-scale telehealth brands and have a well-known weight loss program called the Ro Body Program. Pallas Health is a newer, more focused alternative built around the same medications but with different pricing and a different product philosophy.

This is an honest comparison of the two. We'll tell you when Ro is probably the better fit, and when Pallas makes more sense.

Quick comparison

What each one does well

Both companies work fundamentally the same way: complete an intake, get matched with a licensed provider, receive medication shipped to your door. The differences are in price structure, the breadth of the platform, and the product experience.

Ro's strengths

Established brand and track record. Ro has been operating since 2017 and has treated millions of patients across their broader telehealth platform (not just weight loss). If brand familiarity and longevity matter to you, that's a real advantage.

Broader medication catalog for weight loss. Beyond GLP-1s, Ro offers other prescription options for weight loss — naltrexone/bupropion (Contrave), metformin off-label, and a few others. For patients who can't tolerate GLP-1s or who have specific medical reasons to avoid them, this optionality matters.

Integrated lab work and monitoring. Ro's Body Program includes baseline labs and periodic follow-up labs as part of the service. This is genuinely useful, particularly for patients with any cardiometabolic risk factors.

Lower first-month price. Ro's first month at $99 is cheaper than Pallas's flat $269/mo. Pallas doesn't use introductory discounting — the price is the same every month — so if you're just testing whether GLP-1 therapy is for you, Ro's lower upfront cost is real.

Where Pallas is different

All-in subscription pricing. Pallas plans are flat monthly — medication, provider visit, dose adjustments, messaging, and shipping are all included. No extra charges for brand-name decisions, no separate pharmacy billing. What you see is what you pay: a flat $269/mo, the same every month.

Three GLP-1 formats. Pallas offers compounded semaglutide as both a weekly injection and a daily oral tablet, plus compounded tirzepatide injection. Patients who prefer not to inject have a bona-fide oral option without leaving the platform.

Ongoing messaging, included unlimited. Every Pallas plan includes unlimited provider messaging — particularly useful during the first 30 days of managing titration side effects. No metered interactions, no escalation tiers.

Smaller company, more attention. Pallas is newer and smaller. For some patients that's a negative (less track record), for others a positive (faster responses, clearer accountability). Compare their provider response times with Ro's and decide which experience you value more.

The pricing breakdown, honestly

Pricing is the single biggest difference between the two, and it's worth understanding what's actually being compared.

Compounded GLP-1, first month

• Pallas: a flat $269/mo. Includes intake visit, the first month of semaglutide or tirzepatide (whichever your provider prescribes), and shipping.
• Ro Body Program: $99 intro price on compounded plans, billed monthly thereafter. Some users report additional fees for lab work at onboarding.

Winner (first month): Ro

Compounded GLP-1, ongoing (months 2–12)

• Pallas: a flat $269/mo, the same as month one. All-inclusive — medication, ongoing provider care, shipping.
• Ro: $145/mo on the compounded program as of the latest published pricing, with possible adds for brand switches or extra services.

Winner (ongoing): Ro, but verify their current pricing — Ro has adjusted pricing multiple times since launching the program, and the gap has narrowed over time.

Brand-name (Wegovy® or Zepbound®)

Both platforms can write brand-name prescriptions, but neither waives the list price of the medication itself. Expect ~$1,100–1,400/mo for brand-name Wegovy® or Zepbound® regardless of which telehealth provider you go through, with insurance potentially bringing it down significantly if your plan covers weight-loss GLP-1s.

Winner: Tie — this is about insurance coverage, not the platform.

Product experience differences

Three things are worth considering beyond price.

1. How they frame weight loss

Ro positions their program as a broad "Body Program" — lifestyle, accountability, optional GLP-1. They lean hard on habit coaching and behavioral framing. Some patients love this (more structure, more hand-holding); others find it unnecessary if they already know how to eat and just want the medication.

Pallas takes a more direct approach: here's the medication, here's a licensed provider who adjusts dosing, here's messaging when you need it. Less lifestyle curriculum, less coaching. This appeals to patients who want a medication-first, self-directed experience without the wellness app overhead.

2. Intake and qualification

Both intakes are online, take about 5 minutes, and ask similar medical questions. Ro's is more branded/styled with more coaching copy; Pallas's is more clinical and to-the-point. Either qualifies you within a business day.

3. Pharmacy and shipping

Both platforms use US-licensed compounding pharmacies for compounded medications and real retail pharmacies for brand-name. Shipping times are broadly similar (2–5 business days), though any specific patient's experience depends on pharmacy routing and state.

Who should choose which

Ro is probably the better fit if:

• You want the lowest possible starting price
• You value a structured coaching layer alongside the medication
• You need non-GLP-1 weight loss options (Contrave, metformin, etc.)
• Brand familiarity matters to you
• You like the idea of integrated periodic lab work as part of the program

Pallas is probably the better fit if:

• You want transparent, flat-rate all-inclusive pricing ongoing
• You want oral semaglutide as well as injection options
• You want unlimited, ongoing provider messaging without tiering
• You prefer a more direct, medication-first approach without a lifestyle curriculum
• You want to support a smaller, newer brand where you have more direct line to support

Either works well if:

• You've tried GLP-1 therapy before and know what you want
• You're not on a strict budget and are choosing on product experience
• You live in a state with straightforward telehealth regulations

Switching between them

If you start with one and want to switch, both platforms support clean transitions. Bring a copy of your prescription history (patient portal export), your current dose, and any recent lab work. A new provider at the destination platform picks up from where you are — no need to restart titration unless you've been off medication for more than 4 weeks.

Frequently asked questions

Is Ro cheaper than Pallas overall? For the first year on compounded medications, yes — based on current published pricing, Ro is roughly $150–200 cheaper across 12 months. The gap narrows over time and has shifted multiple times. Check current pricing on both sites before signing up.

Which one has better doctors? Both platforms use licensed US providers, and both are required to match board-certified physicians or nurse practitioners licensed in your state. There's no public data showing one has consistently "better" doctors — it's more about individual provider match and responsiveness.

Do they ship in discreet packaging? Yes, both ship in plain boxes without medication branding on the outside.

Can I use my HSA or FSA? Typically yes on compounded medications (they're prescription healthcare expenses), but check with your HSA/FSA administrator — rules vary. Both platforms provide receipts suitable for reimbursement.

What about insurance? Neither platform processes insurance directly for compounded programs — you pay out of pocket. For brand-name prescriptions, both can write scripts that you can submit for insurance reimbursement separately, but coverage for weight-loss GLP-1s is highly inconsistent across plans.

Can I switch from compounded to brand-name later? On both platforms, yes. Work with your provider on the transition. Pricing changes substantially when you switch to brand-name — budget accordingly.

Bottom line: Ro is cheaper upfront and has the longer track record. Pallas is more transparent on ongoing pricing, includes unlimited provider messaging by default, and offers compounded semaglutide in both injection and oral form. If price is your primary constraint, Ro probably wins. If you want an all-inclusive medication-first experience with multiple GLP-1 formats, Pallas is worth a look.